Atara Biotherapeutics to Participate at the Stifel Healthcare Conference

THOUSAND OAKS, Calif.–(BUSINESS WIRE)–Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases, today announced that AJ Joshi, MD, Chief Medical Officer, and Utpal Koppikar, Chief Financial Officer, will participate…